DYSF and neuromuscular disease caused by qualitative or quantitative defects of dysferlin: Furthermore, genetic ablation of C3 in dysferlin-deficient mice reduced disease severity, indicating that activation of C3 accelerates muscle damage in dysferlin-null mice and that complement-mediated injury is central to the pathogenesis of dysferlinopathy [51].